Board of Directors | epilepsy.com

Place Your Advertisement Here. All ad revenues support the mission of the Epilepsy Therapy Project.

Wed, 2/8/2012

Welcome to the redesigned epilepsy.com

It is now easier and faster than ever to access news, articles and community content. With less clutter and an improved navigation system, your favorite content is now only a click away.

The new features include:

Streamlined design with less clutter to promote important content and sections
New slider masthead
New horizontal menu across the site to ease top level navigation
Re-designed content pages that are easier to navigate
Overall new, fresh look!

Advertisement

Place Your Advertisement Here

Take control of your epilepsy and seizures. Seizure management has never been easier.

TAKE CONTROL TODAY

Board of Directors

Your Email: *

Your Name: *

Send To: *
Enter multiple addresses on separate lines or separate them with commas.

Message Subject: (Your Name) has forwarded a page to you from epilepsy.com

Message Body: (Your Name) thought you would enjoy the following page from epilepsy.com.

Captcha
Type the words in the image

Email this page
Share on Twitter
Share on Facebook
View/Print content

The Epilepsy Therapy Project Board of Directors is a core group of leaders in the business and science community who give their time and personal resources to pursue the ETP mission. They are dedicated to enhancing the scope of our organization to accelerate the developmment of new therapies to reach people with epilepsy and seizures.

Warren Lammert: Chairman & Co-Founder; Founder, Granite Point Capital
Orrin Devinsky, M.D.: Co-Founder; Vice President for Translational Programs; Scientific Advisory Board; Professor of Neurology, Neurosurgery and Psychiatry and Director, NYU Comprehensive Epilepsy Center, New York University
Priscilla Burton: CEO, Epilepsy Therapy Project
Stephen D. Collins, M.D., Ph.D.: President and Chief Executive Officer, NeuroTherapeutics Pharma, Inc.
Tom Ferry: CEO, Curaspan Health Group
Frank Fischer: President & CEO, NeuroPace, Inc.
Jacqueline French, M.D.: Vice President for Clinical Research; Chair, Scientific Advisory Board; Professor of Neurology, NYU Comprehensive Epilepsy Center, New York University; Director of the Epilepsy Study Consortium
May Liang: General Counsel and Chief Financial Officer for Open-Concept Systems, Inc.
Kevin Malone: President and Founder, Greenrock Research
Garry E. Menzel, Ph.D.: Chair, Business Advisory Board, Executive Vice President Corporate Development and Finance, Regulus Therapeutics
Anita O’Connor: Vice President of Client Services and CFO at ETHOS Health Communications
Roger J. Porter, M.D.: Chief Scientific Officer, Epilepsy Therapy Project
David A. Sadock: President & CEO, Ethos Health Communications
Nancy Santilli, B.S.N., M.S.N.: VP Commercial Strategy and Portfolio Planning, Endo Pharmaceuticals, Inc.
Steven C. Schachter, M.D.: Professor of Neurology and Director of Research, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center
Randy Siegel: President, Local Digital Strategy, Advance Publications Inc
Howard Soule, Ph.D.: Executive Vice President and Chief Science Officer, Prostate Cancer Foundation; Senior Fellow, Milken Institute
Kim Macher: (ex officio) Executive Director, Epilepsy Therapy Project

Continue to: Scientific Advisory Board